PUBLICATIONS AND PresentationS
Discover the main highlights of our industry in our latest publications.
Quick links
Presentation
Publication
Key Economic & Value Considerations in the US
Market for PPTs
Market for PPTs
Key Economic & Value Considerations for PDMPs
in Europe
in Europe
Plasma donation: New thinking to serve Europe’s patients -- Practices & approaches for countries
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mar 4, 2021
Immunoglobulin Replacement Therapy Cost-Effectiveness Study
Common variable immunodeficiency disorders (CVID), the most common form of primary antibody deficiency, are rare conditions associated with considerable morbidity and mortality.
All
Publication
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247941
Mar 4, 2021
Immunoglobulin Replacement Therapy Cost-Effectiveness Study
Common variable immunodeficiency disorders (CVID), the most common form of primary antibody deficiency, are rare conditions associated with considerable morbidity and mortality.
All
Publication
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247941
Dec 9, 2020
Europe's Need for More Plasma – Event Report
An online roundtable event entitled “Europe’s need for more plasma – before, during and after Covid-19: challenges and possible solutions”, organized and co-hosted by Member of the European Parliament (MEP) Simona Bonafè, (S&D, Italy) and MEP César Luena (S&D, Spain), and moderated by Peter O’Donnell, a Freelance reporter, took place on December 9, 2020.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e9077ae02d4cd30a5374_Event%20report%20on%20Europe%20s%20need%20for%20more%20plasma_%2009.12.2020.pdf
Dec 9, 2020
Europe's Need for More Plasma – Event Report
An online roundtable event entitled “Europe’s need for more plasma – before, during and after Covid-19: challenges and possible solutions”, organized and co-hosted by Member of the European Parliament (MEP) Simona Bonafè, (S&D, Italy) and MEP César Luena (S&D, Spain), and moderated by Peter O’Donnell, a Freelance reporter, took place on December 9, 2020.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e9077ae02d4cd30a5374_Event%20report%20on%20Europe%20s%20need%20for%20more%20plasma_%2009.12.2020.pdf
Nov 3, 2020
Plasma Saves Lives: Addressing the COVID-19 Pandemic
The Pathogen Safety Steering Committee (PSSC) issued a statement confirming that the coronavirus is not a threat to the safety of plasma-deriver therapies. The statement was made available for download in multiple languages including Czech, French, German, Italian, Portugues, and Spanish.
All
Presentation
https://prezi.com/view/NWUEmOxAg50YI92g7rxx/
Nov 3, 2020
Plasma Saves Lives: Addressing the COVID-19 Pandemic
The Pathogen Safety Steering Committee (PSSC) issued a statement confirming that the coronavirus is not a threat to the safety of plasma-deriver therapies. The statement was made available for download in multiple languages including Czech, French, German, Italian, Portugues, and Spanish.
All
Presentation
https://prezi.com/view/NWUEmOxAg50YI92g7rxx/
Nov 1, 2020
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years experience of the plasma protein manufacturers
Nanofiltration entails the filtering of protein solutions through membranes with pores of nanometric sizes that have the capability to effectively retain a wide range of viruses.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/32815181/
Nov 1, 2020
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years experience of the plasma protein manufacturers
Nanofiltration entails the filtering of protein solutions through membranes with pores of nanometric sizes that have the capability to effectively retain a wide range of viruses.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/32815181/
No results found